Forbes: The Future Of Psychedelic Medicine Might Skip The Trip

Summary: In Forbes, psychedelic experts provide arguments against the removal of the psychedelic properties from psychedelic substances, an approach that is being explored by researchers with government funding.

“Psychedelic research pioneer Rick Doblin, who founded the Multidisciplinary Association for Psychedelic Studies in 1986, thinks the idea of a non-psychedelic psychedelic compound is a ‘bogus’ pipedream,” explains Forbes.

Originally appearing here.